ADAR1 Capital Management »

ACADIA Pharmaceuticals shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of ACADIA Pharmaceuticals (ACAD) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in ACADIA Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including ACADIA Pharmaceuticals held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ACADIA Pharmaceuticals by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $355k 23k 15.38
2024-06-30 $21k 1.3k 16.25
2024-03-31 $9.2k 500 18.49

More positions owned by ADAR1 Capital Management

Cytokinetics Com New (CYTK)
Protagonist Therapeutics (PTGX)
Bridgebio Pharma (BBIO)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Zura Bio Class A Ord Shs (ZURA)
Zai Lab Adr (ZLAB)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Aa Mission Acquisition Corp Ord Shs Cl A (AAM)
Mineralys Therapeutics (MLYS)
Syndax Pharmaceuticals (SNDX)

View all positions for ADAR1 Capital Management

Top funds holding ACADIA Pharmaceuticals

Baker Bros. Advisors
Vanguard Group
Rtw Investments
BlackRock
State Street Corporation
D. E. Shaw & Co
Fred Alger Management
Geode Capital Management
Palo Alto Investors
SG Americas Securities
First Trust Advisors
Millennium Management
Goldman Sachs Group
Deutsche Bank Aktiengesellschaft
Tang Capital Management

View all funds holding ACADIA Pharmaceuticals